Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Evaluation of the Drug–Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP‐5862, Using a Physiologically‐Based Pharmacokinetic Modeling ApproachCPT: pharmacometrics and systems pharmacology, 2019-07, Vol.8 (7), p.489-499 [Peer Reviewed Journal]2019 The Authors published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2163-8306 ;EISSN: 2163-8306 ;DOI: 10.1002/psp4.12408 ;PMID: 31044521Full text available |
2 |
Material Type: Article
|
![]() |
Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient SubgroupsClinical and translational science, 2019-03, Vol.12 (2), p.151-163 [Peer Reviewed Journal]2018 University of Liverpool. published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2018 University of Liverpool. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.12585 ;PMID: 30221827Full text available |
3 |
Material Type: Article
|
![]() |
Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and OpportunitiesClinical and translational science, 2016-04, Vol.9 (2), p.89-104 [Peer Reviewed Journal]2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics ;2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.12391 ;PMID: 26924066Full text available |
4 |
Material Type: Article
|
![]() |
Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on SarcopeniaJournal of cachexia, sarcopenia and muscle, 2012-09, Vol.3 (3), p.181-190 [Peer Reviewed Journal]Springer-Verlag 2012 ;2012 The Authors. Published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2012. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1007/s13539-012-0078-2 ;PMID: 22865205Full text available |
5 |
Material Type: Article
|
![]() |
Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastasesMolecular oncology, 2016-12, Vol.10 (10), p.1575-1584 [Peer Reviewed Journal]2016 Federation of European Biochemical Societies ;Copyright © 2016 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. ;Copyright John Wiley & Sons, Inc. Dec 2016 ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1016/j.molonc.2016.10.001 ;PMID: 28029553Digital Resources/Online E-Resources |
6 |
Material Type: Article
|
![]() |
Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology NetworkCPT: pharmacometrics and systems pharmacology, 2019-05, Vol.8 (5), p.259-272 [Peer Reviewed Journal]2019 The Authors published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2163-8306 ;EISSN: 2163-8306 ;DOI: 10.1002/psp4.12381 ;PMID: 30667172Full text available |
7 |
Material Type: Article
|
![]() |
‘Maximising shareholder value’: a detailed insight into the corporate political activity of the Australian food industryAustralian and New Zealand journal of public health, 2017-04, Vol.41 (2), p.165-171 [Peer Reviewed Journal]2017 Copyright 2017 THE AUTHORS. ;2017 The Authors ;2017 The Authors. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1326-0200 ;EISSN: 1753-6405 ;DOI: 10.1111/1753-6405.12639 ;PMID: 28110500Full text available |
8 |
Material Type: Article
|
![]() |
Pharmacokinetics of Anakinra in Subjects of Heavier vs. Lighter Body WeightsClinical and translational science, 2019-07, Vol.12 (4), p.371-378 [Peer Reviewed Journal]2019 Amgen Inc. and Swedish Orphan Biovitrum. published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019 Amgen Inc. and Swedish Orphan Biovitrum. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.12622 ;PMID: 30884170Full text available |
9 |
Material Type: Article
|
![]() |
Clinical Pharmacology and Translational Aspects of Bispecific AntibodiesClinical and translational science, 2017-05, Vol.10 (3), p.147-162 [Peer Reviewed Journal]2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics ;2017. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.12459 ;PMID: 28297195Full text available |
10 |
Material Type: Article
|
![]() |
A persistent influence of supernovae on biodiversity over the PhanerozoicEcology and evolution, 2023-03, Vol.13 (3), p.e9898-n/a [Peer Reviewed Journal]2023 The Author. published by John Wiley & Sons Ltd. ;2023 The Author. Ecology and Evolution published by John Wiley & Sons Ltd. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-7758 ;EISSN: 2045-7758 ;DOI: 10.1002/ece3.9898 ;PMID: 36937070Full text available |
11 |
Material Type: Article
|
![]() |
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific moleculeCancer science, 2019-02, Vol.110 (2), p.761-770 [Peer Reviewed Journal]2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13907 ;PMID: 30537002Full text available |
12 |
Material Type: Article
|
![]() |
Physiologically Based Pharmacokinetic Model to Assess the Influence of Blinatumomab‐Mediated Cytokine Elevations on Cytochrome P450 Enzyme ActivityCPT: pharmacometrics and systems pharmacology, 2015-09, Vol.4 (9), p.507-515 [Peer Reviewed Journal]2015 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. ;2015. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. 2015 ;ISSN: 2163-8306 ;EISSN: 2163-8306 ;DOI: 10.1002/psp4.12003 ;PMID: 26451330Full text available |
13 |
Material Type: Article
|
![]() |
Suggestions for new organizational‐level item pools for the national Stress Check Program from management philosophy and mission statement: A qualitative study using unsupervised learningJournal of occupational health, 2022-01, Vol.64 (1), p.e12335-n/a [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of The Japan Society for Occupational Health ;2022 The Authors. Journal of Occupational Health published by John Wiley & Sons Australia, Ltd on behalf of The Japan Society for Occupational Health. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1348-9585 ;ISSN: 1341-9145 ;EISSN: 1348-9585 ;DOI: 10.1002/1348-9585.12335 ;PMID: 35587039Full text available |
14 |
Material Type: Article
|
![]() |
Magnetic Resonance Imaging Tracking of Ferumoxytol‐Labeled Human Neural Stem Cells: Studies Leading to Clinical UseStem cells translational medicine, 2013-10, Vol.2 (10), p.766-775 [Peer Reviewed Journal]2013 AlphaMed Press ;Copyright John Wiley & Sons, Inc. Oct 2013 ;AlphaMed Press 1066-5099/2013/$20.00/0 2013 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2013-0049 ;PMID: 24014682Full text available |
15 |
Material Type: Article
|
![]() |
Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncologyClinical and translational science, 2018-07, Vol.11 (4), p.345-351 [Peer Reviewed Journal]2018 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics ;2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.12540 ;PMID: 29392871Full text available |
16 |
Material Type: Article
|
![]() |
Adipose Stromal Cells Repair Pressure Ulcers in Both Young and Elderly Mice: Potential Role of Adipogenesis in Skin RepairStem cells translational medicine, 2015-06, Vol.4 (6), p.632-642 [Peer Reviewed Journal]2015 AlphaMed Press ;AlphaMed Press. ;Copyright John Wiley & Sons, Inc. Jun 2015 ;AlphaMed Press 2015 ;ISSN: 2157-6564 ;EISSN: 2157-6580 ;DOI: 10.5966/sctm.2014-0235 ;PMID: 25900728Full text available |
17 |
Material Type: Article
|
![]() |
Does chief executive compensation predict financial performance or inaccurate financial reporting in listed companies: A systematic reviewCampbell systematic review, 2023-12, Vol.19 (4), p.e1370-n/a [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Ltd on behalf of The Campbell Collaboration. ;2023 The Authors. Campbell Systematic Reviews published by John Wiley & Sons Ltd on behalf of The Campbell Collaboration. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1891-1803 ;EISSN: 1891-1803 ;DOI: 10.1002/cl2.1370 ;PMID: 38089569Full text available |
18 |
Material Type: Article
|
![]() |
Association of circulating tumor DNA from the cerebrospinal fluid with high‐risk CNS involvement in patients with diffuse large B‐cell lymphomaClinical and translational medicine, 2021-01, Vol.11 (1), p.e236-n/a [Peer Reviewed Journal]2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2001-1326 ;EISSN: 2001-1326 ;DOI: 10.1002/ctm2.236 ;PMID: 33463068Full text available |
19 |
Material Type: Article
|
![]() |
Financing corporate tax cuts with shareholder taxesQuantitative economics, 2022-01, Vol.13 (1), p.315-354 [Peer Reviewed Journal]Copyright © 2022 The Authors. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7323 ;EISSN: 1759-7331 ;DOI: 10.3982/QE1167Full text available |
20 |
Material Type: Article
|
![]() |
Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samplesCancer science, 2018-04, Vol.109 (4), p.1177-1184 [Peer Reviewed Journal]2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13511 ;PMID: 29363250Full text available |